Пятница, 29.03.2024, 05:27
Главная Регистрация Вход
Приветствую Вас, Гость · RSS
Меню сайта
реклама
Полиграфия в Днепре
Другие города

Добавить объявления 

В других городах Украины

Добавить в АР Крым

Добавить в Киев

Добавить в Харьков

Добавить в Одессу

Добавить в Днепропетровск

Добавить в Донецк

Добавить в Запорожье

Добавить во Львов

Добавить в Кривой Рог

Добавить в Николаев

Добавить в Мариуполь

Добавить в Луганск

Добавить в Севастополь

Добавить в Винница

Добавить в Макеевка

Добавить в Симферополь

Добавить в Херсон

Добавить в Полтава

Добавить в Чернигов

Добавить в Черкассы

Добавить в Житомир

Добавить в Сумы

Добавить в Хмельницкий

Добавить в Горловка

Наш опрос
Оцените мой сайт
Всего ответов: 15
Друзья сайта
  • Объявления Днепропетровск
  • Объявления Одесса
  • Объявления Харьков
  • Объявления Донецк
  • Объявления Киев
  • Объявления Кривой рог
  • Объявления Запорожье
  • Объявления Мариуполь
  • Объявления Николаев
  • Объявления Львов
  • Объявления Крым
  • куплю шины шины Днепропетровск купить шины Киев
  • Статистика
    Форма входа
     Доска объявлений Крыма
    Главная » Доска объявлений » Услуги в разных сферах » Страхование [ Добавить объявление ]

    В категории объявлений: 4
    Показано объявлений: 1-4


    Сортировать по: Дате · Названию · Рейтингу · Комментариям · Просмотрам

    Mikhail V. Blagosklonny graduated with an MD and PhD from First Pavlov State Medical
    University of St. Petersburg, RUS. Dr. Misha V. Blagosklonny subsequently
    Moved to America, where he received the prestigious Fogarty Fellowship from the National Institutes of Health.
    Within the period of his fellowship in Leonard Neckers’ lab at the National
    Cancer Institute (NCI), he was a co-author of 18 publications on
    Different biomedical topics, like targeting
    HSP90, p53, Bcl2, Erb2, and Raf-1. He also was the last writer for a clinical phase I/II
    Trial publication.
     
    After authoring seven papers within the period of a brief yet fruitful
    Senior research fellowship in the El-Deiry Cancer Research Lab at the University of Pennsylvania,
    Dr. Blagosklonny returned to NCI to team up with Tito Fojo. Together, they
    Published 26 papers. Moreover, Dr. Misha Blagosklonny published many of experimental research papers and theoretical articles as lead
    Writer. These sole-author articles
    Included two crucial themes.
    The first of those discussed selectively killing cancer
    Cells with deregulated cell cycle or drug resistance by
    Validation their resistance. The outcomes and underlying
    Concept were so revolutionary that they were incorrectly cited by
    Other scientists as “reversal of resistance, ” even though the article was
    Titled, “Exploiting of drug resistance instead of its reversal. ” One big
    Supporter of this concept was the world-famous scientist Arthur Pardee, with whom Dr.
    Blagosklonny co-authored a joint paper in 2001.
     
    The second topic throughout Dr. Blagosklonny’s sole-author works
    Is a research methodology to come up with knowledge by
    Uniting a few facts together from seemingly unrelated areas.
    This results in new notions containing testable forecasts, which in
    Turn can be “tested” via analyzing the literature further. Likewise, the
    Notion was co-authored by Arthur Pardee in a 2002 article in Nature. The
    First success of the new research methodology was the description of the feedback
    Regulation of p53, as supported by the discovery of mdm2/p53 loop; and the
    Explanation why mutant p53 is always overexpressed, published in 1997. The most
    Noticeable outcome revealed by Dr.
    Blagosklonny’s research methodology is the hyperfunction (or quasi-programmed)
    Theory of aging and the revelation of rapamycin as an exceptionally well-tolerated
    Anti-aging medication, published in 2006. As mentioned in Scientific American,
    Michael Hall, who discovered mTOR in 1991, gives Dr. Blagosklonny recognition for
    “connecting dots that others can’t even see. ”
     
    In 2002, Dr. Blagosklonny became associate professor of medicine at New York Medical College.
    He went on to accept responsibilities as a senior scientist at Ordway
    Research Institute in Albany, New York, in 2005, before receiving another
    Position at Roswell Park Cancer Institute as professor of oncology in 2009.
     
    Since joining Roswell Park Comprehensive Cancer Center in 2009, Dr. Blagosklonny
    Has studied the prevention of cancer (an age-related disease) via
    Stopping body aging — in other words, “preventing cancer
    Via staying young. ” His laboratory closely worked together with
    Andrei Gudkov’s and finalized research on the suppression of
    Cellular senescence, namely suppression of cellular conversion from healthy quiescence to
    Permanent senescence. This led to the discovery of extra anti-aging
    Medicines besides rapamycin. The cell culture studies were
    Accompanied by studies in mice, including several models like
    Normal and aging mice, p53-deficient mice, and mice on a high-fat diet.
     
    Dr. Misha Blagosklonny has also published extensively on the prevention of cellular
    Senescence via rapamycin and other mTOR inhibitors, life
    Prolongation and cancer stoppage in mice, and combinations of anti-
    Aging medications to be appliedamong humans. A
    Rapamycin-based combination of seven clinically available drugs has
    Been named the “Koschei Formula” and is now used for the treatment of aging in patients
    At the Alan Green Clinic in Little Neck, New York.

     

    Страхование | Просмотров: 240 | Дата: 15.10.2019 | Комментарии (0)

    Misha V. Blagosklonny graduated with an MD and PhD from First Pavlov State Medical
    University of St. Petersburg, Russia. Dr. Mikhail V. Blagosklonny subsequently
    Immigrated to America, where he received the prestigious Fogarty Fellowship from the National Institutes of Health.
    Within the period of his fellowship in Leonard Neckers’ laboratory at the National
    Cancer Institute (NCI), he was a co-author of 18 publications on
    Diverse biomedical topics, suchas targeting
    HSP90, p53, Bcl2, Erb2, and Raf-1. He also was the last writer for a clinical phase I/II
    Trial publication.

    After authoring seven papers during a brief yet resulting
    Senior research fellowship in the El-Deiry Cancer Research Lab at the University of Pennsylvania,
    Dr. Blagosklonny returned to NCI to team up with Tito Fojo. Together, they
    Published 26 papers. In addition, Dr. Misha Blagosklonny published anumber of experimental research papers and theoretical articles as sole
    Writer. Those sole-author publications
    Included two crucial topics.
    The first of these mentioned selectively killing cancer
    Cells with deregulated cell cycle or drug resistance via
    Verifying their resistance. The results and underlying
    Notion were so revolutionary that they were inadequately cited by
    Other scientists as “reversal of resistance, ” even though the publication was
    Named, “Exploiting of drug resistance instead of its reversal. ” One major
    Supporter of this concept was the world-famous scientist Arthur Pardee, with whom Dr.
    Blagosklonny co-authored a joint paper in 2001.

    The second topic throughout Dr. Blagosklonny’s sole-author articles
    Is a research methodology to produce knowledge by
    Bringing a few facts together from seemingly unrelated fields.
    This results in new notions with testable forecasts, which in
    Turn can be “tested” via analyzing the literature further. Once again, the
    Concept was co-authored by Arthur Pardee in a 2002 publication in Nature. The
    First success of the new research method was the description of the feedback
    Regulation of p53, as supported by the discovery of mdm2/p53 loop; and the
    Explanation why mutant p53 is always overexpressed, published in 1997. The most
    Important result revealed by Dr.
    Blagosklonny’s research methodology is the hyperfunction (or quasi-programmed)
    Theory of aging and the revelation of rapamycin as an exclusively well-tolerated
    Anti-aging drug, published in 2006. As mentioned in Scientific American,
    Michael Hall, who discovered mTOR in 1991, gives Dr. Blagosklonny credit for
    “connecting dots that others cannot even see. ”

    In 2002, Dr. Blagosklonny became associate professor of medicine at New York Medical College.
    He went on to accept responsibilities as a senior scientist at Ordway
    Research Institute in Albany, New York, in 2005, before accepting another
    Position at Roswell Park Cancer Institute as professor of oncology in 2009.

    Since joining Roswell Park Comprehensive Cancer Center in 2009, Dr. Blagosklonny
    Has studied the prevention of cancer (an age-related disease) by
    Preventing body aging — in other words, “preventing cancer
    Via staying young. ” His lab closely collaborated with
    Andrei Gudkov’s and performed research on the suppression of
    Cellular senescence, namely suppression of cellular conversion from healthy quiescence to
    Permanent senescence. This led to the discovery of extra anti-aging
    Medicines beyond rapamycin. The cell culture studies were
    Complemented by studies in mice, including several models such as
    Normal and aging mice, p53-deficient mice, and mice on a high-fat diet.

    Dr. Misha Blagosklonny has also published extensively on the stoppage of cellular
    Senescence by rapamycin and other mTOR inhibitors, life
    Extension and cancer prevention in mice, and combinations of anti-
    Aging medicines to be appliedamong humans. A
    Rapamycin-based combination of seven clinically available medications has
    Been named the “Koschei Formula” and is now utilized for the treatment of aging in patients
    At the Alan Green Clinic in Little Neck, New York.
    https://www.roswellpark.org/mikhail-blagosklonny
    https://www.tandfonline.com/doi/pdf/10.4161/cbt.8.9.8899
    https://tandfonline.com/doi/abs/10.4161/cbt.8.9.8899

    Страхование | Просмотров: 303 | Дата: 30.09.2019 | Комментарии (0)

    Страховая компания "ГАРМЕД" обеспечит максимально выгодные условия по страхованию частных и коммерческих рисков. Виды страхования: • транспортных рисков при перевозке грузов и пассажиров, • рисков в строительстве и производстве, • имущества физических и юридических лиц, • автогражданской ответственности водителей, • медицинское страхование. Большой выбор условий страхования по любому из видов услуг, прозрачная процедуру урегулирования убытков – вот основные принципы нашей работы.
    Страхование | Просмотров: 341 | Дата: 13.11.2015 | Комментарии (0)

    Размещение объявлений на электронных досках объявлений это эффективный вид интернет рекламы. Регистрируем аккаунт. Выбираем подходящую рубрику. Подаем объявление на максимальный срок. Соответствуем правилам досок и уважаем работу модераторов. Только ручное размещение объявлений на досках объявлений дает хороший результат в привлечении новых клиентов.
    Квартира | Просмотров: 4250 | Дата: 09.05.2012 | Комментарии (0)

    Copyright MyCorp © 2024
    Реклама
    Газовые котлы в Днепре
    Поиск
    города россии

    Добавить объявления 

    В других городах России

    Добавить в Москва

    Добавить в Ст.Петербург

    Добавить в Новосибирск

    Добавить в Екатеринбург

    Добавить в Н.Новгород

    Добавить в Самара

    Добавить в Омск

    Добавить в Казань

    Добавить в Челябинск

    Добавить в Ростов

    Добавить в Уфа

    Добавить в Волгоград

    Новости Крыма
    Конструктор сайтов - uCoz
    объявления Крыма для нас являются очень важным фактором работы, потому что наша доска объявлений будет работать как газета объявления Крыма и в ней, каждый житель Крыма сможет разместить бесплатные объявления Крыма, а так же мы знаем что в Крыму естьсорока Крым объявления и очень рады таким конкурентам. Так же на нашем сайте вы сможети разместить объявления по теме отдых в Крыму летом и зимой.